Prince Street Capital Management LLC Athenex, Inc. Transaction History

Prince Street Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$5.71 - $15.85 $370,579 - $1.03 Million	-64,900 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $623,040 - $1.15 Million	64,900 New	64,900 $991,000
Q3 2019 Nov 14, 2019	SELL	$12.16 - $21.0 $1.81 Million - $3.13 Million	-149,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$9.44 - $19.8 $783,520 - $1.64 Million	-83,000 Reduced 35.78%	149,000 $2.95 Million
Q1 2019 May 15, 2019	SELL	$11.11 - $13.49 $3.53 Million - $4.29 Million	-318,000 Reduced 57.82%	232,000 $2.84 Million
Q4 2018 Feb 14, 2019	SELL	$10.24 - $15.49 $737,280 - $1.12 Million	-72,000 Reduced 11.58%	550,000 $6.98 Million
Q2 2018 Aug 14, 2018	SELL	$15.88 - $19.5 $2.62 Million - $3.22 Million	-165,000 Reduced 20.97%	622,000 $11.6 Million
Q1 2018 May 14, 2018	BUY	$13.53 - $17.47 $8.27 Million - $10.7 Million	611,000 Added 347.16%	787,000 $13.4 Million
Q4 2017 Feb 14, 2018	BUY	$14.41 - $19.15 $2.54 Million - $3.37 Million	176,000	176,000 $2.8 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Prince Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Prince Street Capital Management LLC with notifications on news.